Noncentral nervous system systemic embolism in patients with atrial fibrillation: Results from ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) - Orgel, R; Wojdyla, D; Huberman, D (Circ Cardiovasc Qual Outcomes, 2017)
et al.